News | October 17, 2023
Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
New Board of Directors and management team at Suven Pharma also appointed
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Subscribe To Our Newsletter & Stay Updated
